Skip to main content

Regulatory and Washington

  • FDA approves generic cancer drug

    SILVER SPRING, Md. — The Food and Drug Administration has approved a generic version of a cancer drug in a move that the agency said would help relieve shortages.

    The FDA announced the approval of Sun Pharma Global's doxorubicin hydrochloride liposome injection, a generic version of Johnson & Johnson's Doxil. The drug is currently on the agency's list of drugs experiencing shortages.

  • 'Look ahead and be bold,' Anderson urges NACDS members as group marks 80th year

    FORT LAUDERDALE, Fla. — National Association of Chain Drug Stores president and CEO Steve Anderson pledged to be proactive in advocating for pharmacy in the organization's 80th year.

    Speaking at the NACDS' Regional Chain Conference Monday, Anderson said pharmacy stood at an "inflection point," with many more on the horizon.

  • Rite Aid appoints Yong Choe as VP government affairs and public policy

    Rite Aid on Thursday announced the appointment of Yong Choe as VP federal affairs and public policy. Choe previously served as director of business outreach and member services for the Republican Study Committee, chaired by Rep. Jim Jordan of Ohio, and worked in various roles in the government affairs division of the National Association of Chain Drug Stores between 2003 and 2010. In his new position, he will report to EVP pharmacy Robert Thompson.

  • MTM improves outcomes in diabetes patients, study finds

    ARLINGTON, Va. — Face-to-face medication therapy management services can improve health outcomes for patients with diabetes, according to a new study.

  • Novartis recalls Triaminic Syrups and Theraflu Warming Relief Syrups

    PARSIPPANY, N.J. — Novartis Consumer Health on Thursday voluntarily issued a recall of certain lots of Triaminic Syrups and Theraflu Warming Relief Syrups that were manufactured in the United States prior to Dec. 31, 2011. 

    The full recall resulted from a faulty child-resistant feature of the bottle cap may not function properly, enabling the cap to be removed with the tamper-evident seal still in place.

  • FDA approves new drug for potentially deadly ammonia conditions

    SILVER SPRING, Md. — The Food and Drug Administration has approved a new drug for treating some disorders that harm the body's ability to remove ammonia from the blood, the agency said Friday.

  • Unilever completes sale of Skippy brand to Hormel in most markets

    ENGLEWOOD CLIFFS, N.J. — Unilever has mostly completed its sale of the Skippy peanut butter brand to Hormel Foods, the company said Friday.

    The conglomerate said it had completed the $700 million sale of the global business, except for China, where it remains subject to regulatory approval and is expected to close later this year.

    The two companies announced the deal on Jan. 3, including the brand's trademarks and two factories, in the United States and China.

  • ERSP recommends weight-loss supplement manufacturer modify claims

    NEW YORK — The Electronic Retailing Self-Regulation Program on Wednesday determined the National Weight Loss Institute can support general weight-loss claims made in direct-response advertising for Prevoxin, a dietary supplement intended to promote weight loss, but recommended the marketer modify or discontinue certain claims.

X
This ad will auto-close in 10 seconds